March 05, 2015 11:43 AM ET

Pharmaceuticals

Company Overview of Lantheus Medical Imaging, Inc.

Company Overview

Lantheus Medical Imaging, Inc. develops, manufactures, and distributes diagnostic medical imaging products. It offers imaging agents that assist in the diagnosis of heart, vascular, and other diseases using nuclear imaging, echocardiography, and magnetic resonance imaging (MRI) technologies. The company also has clinical and preclinical development pipeline of products that use positron emission tomography and MRI technologies. It principally offers Ablavar, a magnetic resonance angiography agent to evaluate aortoiliac disease in adult patients; DEFINITY Vial, a cardiac ultrasound contrast agent used for suboptimal echocardiograms; Cardiolite, a technetium-based radiopharmaceutical used in m...

Building 200-2

331 Treble Cove Road

North Billerica, MA 01862

United States

Founded in 1956

Phone:

978-671-8001

Fax:

978-671-8860

Key Executives for Lantheus Medical Imaging, Inc.

Chief Executive Officer, President and Director
Age: 51
Chief Financial Officer
Age: 52
Vice President of Manufacturing and Operations
Age: 42
Vice President, General Counsel and Secretary
Age: 53
Chief Medical Officer
Age: 64
Compensation as of Fiscal Year 2014.

Lantheus Medical Imaging, Inc. Key Developments

Lantheus Medical Imaging, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014; Reports Asset Write-Off Charges for the Fourth Quarter Ended December 31, 2014

Lantheus Medical Imaging, Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, revenues were $76,969,000 against $71,668,000 last year. Operating income was $11,800,000 against operating loss of $1,334,000 last year. Income before income taxes was $1,869,000 against loss before income taxes of $11,555,000 last year. Net income was $300,000 against net loss of $12,302,000 last year. Net income, as adjusted was $1,510,000 against net loss, as adjusted of $6,120,000 last year. EBITDA was $17,496,000 against $4,710,000 last year. Adjusted EBITDA was $19,363,000 against $15,157,000 last year. Net cash used in operating activities was $3,875,000 against $3,856,000 last year. Capital expenditures were $2,834,000 against $1,299,000 last year. For the year, revenues were $301,600,000 against $283,672,000 last year. Operating income was $41,809,000 against operating loss of $19,014,000 last year. Income before income taxes was $26,000 against loss before income taxes of $60,664,000 last year. Net loss was $1,169,000 against $61,678,000 last year. Net income, as adjusted was $41,000 against net loss, as adjusted of $48,708,000 last year. EBITDA was $60,557,000 against $6,789,000 last year. Adjusted EBITDA was $70,775,000 against $38,360,000 last year. Net cash provided by operating activities was $11,573,000 against net cash used in operating activities of $15,678,000 last year. Capital expenditures were $8,137,000 against $5,010,000 last year. For the quarter, asset write-off was $107,000 against $18,091,000 last year.

Lantheus Medical Imaging, Inc., Q4 2014 Earnings Call, Mar 04, 2015

Lantheus Medical Imaging, Inc., Q4 2014 Earnings Call, Mar 04, 2015

Lantheus Medical Imaging Announces FDA Approval of Jubilant HollisterStier as New Manufacturing Site for NEUROLITE(R)

Lantheus Medical Imaging, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted approval of a Supplemental New Drug Application (sNDA) that allows Jubilant HollisterStier (JHS) to be a new manufacturing site for its proprietary brain perfusion imaging agent NEUROLITEfont-weight: bold; (Kit of the Preparation of Technetium Tc99m Bicisate for Injection). NEUROLITE, a technetium-based single-photon emission computed tomography (SPECT) radiopharmaceutical agent, provides healthcare providers with critical neurological information for patients.

Similar Private Companies By Industry

Company Name Region
Mitsubishi Pharma America, Inc. United States
Contract Pharmaceuticals Limited Niagara United States
OrgSyn Laboratory, Inc. United States
Silkit Pharma Corporation United States
Enhance Biotech, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Lantheus Medical Imaging, Inc., please visit www.lantheus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.